Mesoblast (NASDAQ: MESO) CEO discloses options expiring through 2032
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Mesoblast Ltd CEO and Managing Director Silviu Itescu reported his existing ownership of Ordinary Shares and stock options. He directly holds 67,756,838 Ordinary Shares and has additional indirect holdings through entities associated with him. He also holds multiple option awards over Ordinary Shares with exercise prices from 0.3500 to 2.4600 per share, expiring between 2026 and 2032.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Itescu Silviu
Role
CEO and Managing Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 673,333 shares (Direct);
Ordinary Shares — 67,756,838 shares (Direct);
Ordinary Shares — 8,821,137 shares (Indirect, Owned by Josaka Investments Pty Ltd, the trustee of Dr. Itescu's self-managed superannuation fund)
Footnotes (1)
- Granted on July 20, 2019. Vesting is dependent on Mr. Itescu achieving certain milestones. Granted on August 26, 2025. These options will vest on August 26, 2026. Granted on September 8, 2021. Vesting is dependent on Mr. Itescu achieving certain milestones. Granted on October 17, 2022. Vesting is dependent on Mr. Itescu achieving certain milestones. Granted on October 16, 2023. Vesting is dependent on Mr. Itescu achieving certain milestones. Granted on August 27, 2024. Vesting is dependent on Mr. Itescu achieving certain milestones. Granted on August 26, 2025. Vesting is dependent on Mr. Itescu achieving certain milestones.
Key Figures
Direct Ordinary Shares: 67,756,838 shares
Indirect Ordinary Shares (superannuation fund): 8,821,137 shares
Indirect Ordinary Shares (Tamit Nominees): 2,380,953 shares
+4 more
7 metrics
Direct Ordinary Shares
67,756,838 shares
Total Ordinary Shares held directly by CEO after reported holdings
Indirect Ordinary Shares (superannuation fund)
8,821,137 shares
Owned by Josaka Investments Pty Ltd, trustee of self-managed superannuation fund
Indirect Ordinary Shares (Tamit Nominees)
2,380,953 shares
Owned by Tamit Nominees Pty Ltd, an Australian corporation owned by Mr. Itescu
Option exercise price
0.3500 per share
Option (right to buy) over 806,666 underlying Ordinary Shares, expiring 2030-10-15
Option exercise price
0.9700 per share
Option (right to buy) over 2,072,000 underlying Ordinary Shares, expiring 2031-08-26
Option exercise price
2.4600 per share
Option (right to buy) over 1,950,000 underlying Ordinary Shares, expiring 2032-08-25
Option exercise price
1.4500 per share
Option (right to buy) over 673,333 underlying Ordinary Shares, expiring 2026-07-19
Key Terms
Option (right to buy), Ordinary Shares, self-managed superannuation fund, indirect ownership, +1 more
5 terms
Option (right to buy) financial
"security_title: Option (right to buy) over Ordinary Shares"
self-managed superannuation fund financial
"Owned by Josaka Investments Pty Ltd, the trustee of Dr. Itescu's self-managed superannuation fund"
indirect ownership financial
"ownership_type: indirect for Ordinary Shares held through related entities"
vesting financial
"Vesting is dependent on Mr. Itescu achieving certain milestones."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What Mesoblast (MESO) holdings did CEO Silviu Itescu report?
He reported direct ownership of 67,756,838 Ordinary Shares, plus indirect holdings of 8,821,137 shares via a self-managed superannuation fund and 2,380,953 shares through Tamit Nominees Pty Ltd. These positions reflect his existing stake, not new share purchases or sales.
How are Silviu Itescu’s indirect Mesoblast (MESO) holdings structured?
Indirect Ordinary Share holdings include 8,821,137 shares owned by Josaka Investments Pty Ltd, trustee of his self-managed superannuation fund, and 2,380,953 shares owned by Tamit Nominees Pty Ltd, an Australian corporation owned by him. These entities hold shares on his behalf.
Do the Mesoblast (MESO) CEO’s options depend on performance milestones?
Several option grants vest only if Mr. Itescu achieves certain milestones, according to the footnotes. Specific grants dated September 8, 2021, October 17, 2022, October 16, 2023, and August 27, 2024 have vesting conditions tied to performance-related achievements.
Are any of the Mesoblast (MESO) CEO’s options time-based vesting only?
One grant dated August 26, 2025 will vest on August 26, 2026 based on time, as stated in the footnotes. Other grants reference vesting that depends on Mr. Itescu achieving specified milestones rather than simple service-based vesting alone.